Skip to Main Content (Press Enter)

Logo UNIME
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze

Competenze e Professionalità
Logo UNIME

|

UNIFIND - Competenze e Professionalità

unime.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  1. Pubblicazioni

Impact of cypermethrin in nephrocytes of freshwater fish Catla catla

Articolo
Data di Pubblicazione:
2021
Abstract:
The kidney of Catla catla, chronically exposed to sub-lethal concentrations (0.24 μg/L and 0.41 μg/L) of cypermethrin revealed a significant elevation in the activity of antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione-s-transferase (GST) and reduced glutathione (GSH) after 15 days, followed by a decline of up to 45 days. Lipid peroxidation (LPO) remained elevated throughout the exposure duration. Histology presented proliferated haematopoietic tissue, tubular and glomerular degeneration. The maximum increase in the mean degree of tissue change (DTC) was observed on the 45th day of treatment. Ultra-structure study depicted cytoplasmic vacuolation, fragmented RER, the proliferation of lysosomes, mitochondrial degeneration, and degenerative changes in the epithelial lining of renal tubules. Principal component analysis (PCA) of various biomarkers generated two components PCI (SOD, GST, GSH, LPO and DTC) and PCII (CAT). These findings suggest that long term exposure to cypermethrin can lead to various pathological alterations in the fish kidney which in turn might interfere with normal renal excretory mechanism.
Tipologia CRIS:
14.a.1 Articolo su rivista
Keywords:
Cypermethrin ; Catla catla; Oxidative stress; Histopathology; Ultrastructure; Chronic toxicity
Elenco autori:
Sharma, Ritu; Jindal, Rajinder; Faggio, Caterina
Autori di Ateneo:
FAGGIO Caterina
Link alla scheda completa:
https://iris.unime.it/handle/11570/3210293
Pubblicato in:
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
Journal
  • Informazioni
  • Assistenza
  • Accessibilità
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Designed by Cineca | 26.4.5.0